{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T06:14:50Z","timestamp":1789107290781,"version":"build-2803163510"},"reference-count":159,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T00:00:00Z","timestamp":1678406400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81771774"],"award-info":[{"award-number":["81771774"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Anhui Province","award":["1708085MH191"],"award-info":[{"award-number":["1708085MH191"]}]},{"name":"the Anhui Key Research and Development Foundation","award":["201904a07020103"],"award-info":[{"award-number":["201904a07020103"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1007\/s10753-023-01795-5","type":"journal-article","created":{"date-parts":[[2023,3,10]],"date-time":"2023-03-10T06:02:34Z","timestamp":1678428154000},"page":"835-852","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Therapeutic Potential of Targeting the NLRP3 Inflammasome in Rheumatoid Arthritis"],"prefix":"10.1007","volume":"46","author":[{"given":"Jie","family":"Gao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinhui","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,10]]},"reference":[{"key":"1795_CR1","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha, D., T. Neogi, A.J. Silman, J. Funovits, D.T. Felson, C.O. Bingham 3rd., et al. 2010. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis and Rheumatism 62: 2569\u20132581. https:\/\/doi.org\/10.1002\/art.27584.","journal-title":"Arthritis and Rheumatism"},{"key":"1795_CR2","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1056\/NEJMra1004965","volume":"365","author":"IB McInnes","year":"2011","unstructured":"McInnes, I.B., and G. Schett. 2011. The pathogenesis of rheumatoid arthritis. New England Journal of Medicine 365: 2205\u20132219. https:\/\/doi.org\/10.1056\/NEJMra1004965.","journal-title":"New England Journal of Medicine"},{"key":"1795_CR3","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen, J.S., D. Aletaha, and I.B. McInnes. 2016. Rheumatoid arthritis. Lancet 388: 2023\u20132038. https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8.","journal-title":"Lancet"},{"key":"1795_CR4","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1136\/annrheumdis-2016-210711","volume":"76","author":"K Chatzidionysiou","year":"2017","unstructured":"Chatzidionysiou, K., S. Emamikia, J. Nam, S. Ramiro, J. Smolen, D. van der Heijde, et al. 2017. Efficacy of glucocorticoids, conventional and targeted synthetic disease-modifying antirheumatic drugs: A systematic literature review informing the 2016 update of The EULAR recommendations for the management of rheumatoid arthritis. Annals of the Rheumatic Diseases 76: 1102\u20131107. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210711.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1795_CR5","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1136\/annrheumdis-2016-210708","volume":"76","author":"S Ramiro","year":"2017","unstructured":"Ramiro, S., A. Sepriano, K. Chatzidionysiou, J.L. Nam, J.S. Smolen, D. van der Heijde, et al. 2017. Safety of synthetic and biological DMARDs: A systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritis. Annals of the Rheumatic Diseases 76: 1101\u20131136. https:\/\/doi.org\/10.1136\/annrheumdis-2016-210708.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1795_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s13075-015-0554-0","volume":"17","author":"A van Walsem","year":"2015","unstructured":"van Walsem, A., S. Pandhi, R.M. Nixon, P. Guyot, A. Karabis, and R.A. Moore. 2015. Relative benefit-risk comparing diclofenac to other traditional non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors in patients with osteoarthritis or rheumatoid arthritis: A network meta-analysis. Arthritis Research & Therapy 17: 66. https:\/\/doi.org\/10.1186\/s13075-015-0554-0.","journal-title":"Arthritis Research & Therapy"},{"key":"1795_CR7","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1093\/rheumatology\/kep096","volume":"48","author":"V Ravindran","year":"2009","unstructured":"Ravindran, V., S. Rachapalli, and E.H. Choy. 2009. Safety of medium- to long-term glucocorticoid therapy in rheumatoid arthritis: A meta-analysis. Rheumatology (Oxford) 48: 807\u2013811. https:\/\/doi.org\/10.1093\/rheumatology\/kep096.","journal-title":"Rheumatology (Oxford)"},{"key":"1795_CR8","doi-asserted-by":"publisher","unstructured":"Strangfeld, A., F. Hierse, R. Rau, G.R. Burmester, B. Krummel-Lorenz, W. Demary,\u00a0et al.\u00a02010. Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBIT. Arthritis Research & Therapy\u00a012. https:\/\/doi.org\/10.1186\/ar2904.","DOI":"10.1186\/ar2904"},{"key":"1795_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1136\/annrheumdis-2016-209285","volume":"76","author":"LK Mercer","year":"2017","unstructured":"Mercer, L.K., J. Askling, P. Raaschou, W.G. Dixon, L. Dreyer, M.L. Hetland, et al. 2017. Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: Results from a collaborative project of 11 European biologic registers. Annals of the Rheumatic Diseases 76: 386\u2013391. https:\/\/doi.org\/10.1136\/annrheumdis-2016-209285.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1795_CR10","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1038\/nri.2016.151","volume":"17","author":"A Liston","year":"2017","unstructured":"Liston, A., and S.L. Masters. 2017. Homeostasis-altering molecular processes as mechanisms of inflammasome activation. Nature Reviews Immunology 17: 208\u2013214. https:\/\/doi.org\/10.1038\/nri.2016.151.","journal-title":"Nature Reviews Immunology"},{"key":"1795_CR11","doi-asserted-by":"publisher","unstructured":"Ben Hamad, M., F. Cornelis, S. Marzouk, G. Chabchoub, Z. Bahloul, A. Rebai,\u00a0et al.\u00a02012. Association study of CARD8 (p.C10X) and NLRP3 (p.Q705K) variants with rheumatoid arthritis in French and Tunisian populations.\u00a0International Journal of Immunogenetics, 39:131\u2013136. https:\/\/doi.org\/10.1111\/j.1744-313X.2011.01070.x.","DOI":"10.1111\/j.1744-313X.2011.01070.x"},{"key":"1795_CR12","doi-asserted-by":"publisher","unstructured":"Shao,\u00a0S., C.J. Chen, G.N. Shi, Y. Zhou, Y.Z. Wei, N.Y. Fan,\u00a0et al.\u00a02021. Therapeutic potential of the target on NLRP3 inflammasome in multiple sclerosis. Pharmacology and Therapeutics\u00a0227. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.107880.","DOI":"10.1016\/j.pharmthera.2021.107880"},{"key":"1795_CR13","doi-asserted-by":"publisher","unstructured":"Dalbeth, N., A.L. Gosling, A. Gaffo, and A. Abhishek. 2021. Gout. Lancet\u00a0397:1843\u20131855.\u00a0https:\/\/doi.org\/10.1016\/S0140-6736(21)00569-9.","DOI":"10.1016\/S0140-6736(21)00569-9"},{"key":"1795_CR14","doi-asserted-by":"publisher","unstructured":"Li, Z., J. Guo, and L. Bi. 2020. Role of the NLRP3 inflammasome in autoimmune diseases. Biomedicine and Pharmacotherapy\u00a0130: 110542. https:\/\/doi.org\/10.1016\/j.biopha.2020.110542.","DOI":"10.1016\/j.biopha.2020.110542"},{"key":"1795_CR15","doi-asserted-by":"publisher","unstructured":"Xia, S., L.R.t. Hollingsworth, and H. Wu. 2020. Mechanism and regulation of gasdermin-mediated cell death. Cold Spring Harbor Perspectives in Biology\u00a012.\u00a0https:\/\/doi.org\/10.1101\/cshperspect.a036400.","DOI":"10.1101\/cshperspect.a036400"},{"key":"1795_CR16","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1097\/BOR.0000000000000277","volume":"28","author":"J Dekkers","year":"2016","unstructured":"Dekkers, J., R.E. Toes, T.W. Huizinga, and D. van der Woude. 2016. The role of anticitrullinated protein antibodies in the early stages of rheumatoid arthritis. Current Opinion in Rheumatology 28: 275\u2013281. https:\/\/doi.org\/10.1097\/BOR.0000000000000277.","journal-title":"Current Opinion in Rheumatology"},{"key":"1795_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13075-015-0901-1","volume":"18","author":"P Lacerte","year":"2016","unstructured":"Lacerte, P., A. Brunet, B. Egarnes, B. Duchene, J.P. Brown, and J. Gosselin. 2016. Overexpression of TLR2 and TLR9 on monocyte subsets of active rheumatoid arthritis patients contributes to enhance responsiveness to TLR agonists. Arthritis Research & Therapy 18: 10. https:\/\/doi.org\/10.1186\/s13075-015-0901-1.","journal-title":"Arthritis Research & Therapy"},{"key":"1795_CR18","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1097\/01.shk.0000225404.51320.82","volume":"26","author":"M Yu","year":"2006","unstructured":"Yu, M., H.C. Wang, A.H. Ding, D.T. Golenbock, E. Latz, C.J. Czura, et al. 2006. HMGB1 signals through toll-like receptor (TLR) 4 and TLR2. Shock 26: 174\u2013179. https:\/\/doi.org\/10.1097\/01.shk.0000225404.51320.82.","journal-title":"Shock"},{"key":"1795_CR19","doi-asserted-by":"publisher","unstructured":"Jiang, C.S.,\u00a0 W.H. Zhu, J. Xu, B. Wang, W.K. Hou, R. Zhang,\u00a0et al.\u00a02014. MicroRNA-26a negatively regulates toll-like receptor 3 expression of rat macrophages and ameliorates pristane induced arthritis in rats. Arthritis Research & Therapy\u00a016. https:\/\/doi.org\/10.1186\/ar4435.","DOI":"10.1186\/ar4435"},{"key":"1795_CR20","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.autrev.2016.12.003","volume":"16","author":"HA Elshabrawy","year":"2017","unstructured":"Elshabrawy, H.A., A.E. Essani, Z. Szekanecz, D.A. Fox, and S. Shahrara. 2017. TLRs, future potential therapeutic targets for RA. Autoimmunity Reviews 16: 103\u2013113. https:\/\/doi.org\/10.1016\/j.autrev.2016.12.003.","journal-title":"Autoimmunity Reviews"},{"key":"1795_CR21","doi-asserted-by":"publisher","unstructured":"Clanchy,\u00a0F.I.L., F. Borghese, J. Bystrom, A. Balog, H. Penn, D.N. Hull,\u00a0et al.\u00a02021. TLR expression profiles are a function of disease status in rheumatoid arthritis and experimental arthritis. Journal of Autoimmunity\u00a0118.\u00a0https:\/\/doi.org\/10.1016\/j.jaut.2021.102597.","DOI":"10.1016\/j.jaut.2021.102597"},{"key":"1795_CR22","doi-asserted-by":"publisher","unstructured":"Sakalyte, R., J. Denkovskij, E. Bernotiene, S. Stropuviene, S.O. Mikulenaite, G. Kvederas,\u00a0et al.\u00a02021. The expression of inflammasomes NLRP1 and NLRP3, Toll-like receptors, and vitamin D receptor in synovial fibroblasts from patients with different types of knee arthritis. Frontiers in Immunology\u00a012: 767512.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2021.767512.","DOI":"10.3389\/fimmu.2021.767512"},{"key":"1795_CR23","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/nprot.2007.173","volume":"2","author":"DD Brand","year":"2007","unstructured":"Brand, D.D., K.A. Latham, and E.F. Rosloniec. 2007. Collagen-induced arthritis. Nature Protocols 2: 1269\u20131275. https:\/\/doi.org\/10.1038\/nprot.2007.173.","journal-title":"Nature Protocols"},{"key":"1795_CR24","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/gt.2011.173","volume":"19","author":"SY Chen","year":"2012","unstructured":"Chen, S.Y., A.L. Shiau, Y.T. Li, Y.S. Lin, C.H. Lee, C.L. Wu, et al. 2012. Suppression of collagen-induced arthritis by intra-articular lentiviral vector-mediated delivery of toll-like receptor 7 short hairpin RNA gene. Gene Therapy 19: 752\u2013760. https:\/\/doi.org\/10.1038\/gt.2011.173.","journal-title":"Gene Therapy"},{"key":"1795_CR25","doi-asserted-by":"publisher","first-page":"518","DOI":"10.2353\/ajpath.2007.060657","volume":"170","author":"SM Sacre","year":"2007","unstructured":"Sacre, S.M., E. Andreakos, S. Kiriakidis, P. Amjadi, A. Lundberg, G. Giddins, et al. 2007. The toll-like receptor adaptor proteins MyD88 and Mal\/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. American Journal of Pathology 170: 518\u2013525. https:\/\/doi.org\/10.2353\/ajpath.2007.060657.","journal-title":"American Journal of Pathology"},{"key":"1795_CR26","doi-asserted-by":"publisher","first-page":"4965","DOI":"10.4049\/jimmunol.0801563","volume":"182","author":"QQ Huang","year":"2009","unstructured":"Huang, Q.Q., R. Sobkoviak, A.R. Jockheck-Clark, B. Shi, A.M. Mandelin, P.P. Tak, et al. 2009. Heat shock protein 96 is elevated in rheumatoid arthritis and activates macrophages primarily via TLR2 signaling. Journal of Immunology 182: 4965\u20134973. https:\/\/doi.org\/10.4049\/jimmunol.0801563.","journal-title":"Journal of Immunology"},{"key":"1795_CR27","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/Itt.S288547","volume":"10","author":"S Unterberger","year":"2021","unstructured":"Unterberger, S., K.A. Davies, S.B. Rambhatla, and S. Sacre. 2021. Contribution of toll-like receptors and the NLRP3 inflammasome in rheumatoid arthritis pathophysiology. Immunotargets Ther 10: 285\u2013298. https:\/\/doi.org\/10.2147\/Itt.S288547.","journal-title":"Immunotargets Ther"},{"key":"1795_CR28","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/art.30081","volume":"63","author":"J Sokolove","year":"2011","unstructured":"Sokolove, J., X.Y. Zhao, P.E. Chandra, and W.H. Robinson. 2011. Immune complexes containing citrullinated fibrinogen costimulate macrophages via toll-like receptor 4 and Fc gamma receptor. Arthritis Rheum-Us 63: 53\u201362. https:\/\/doi.org\/10.1002\/art.30081.","journal-title":"Arthritis Rheum-Us"},{"key":"1795_CR29","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41423-019-0201-9","volume":"17","author":"X Dong","year":"2020","unstructured":"Dong, X., Z. Zheng, P. Lin, X. Fu, F. Li, J. Jiang, et al. 2020. ACPAs promote IL-1beta production in rheumatoid arthritis by activating the NLRP3 inflammasome. Cellular & Molecular Immunology 17: 261\u2013271. https:\/\/doi.org\/10.1038\/s41423-019-0201-9.","journal-title":"Cellular & Molecular Immunology"},{"key":"1795_CR30","doi-asserted-by":"publisher","unstructured":"Yang,\u00a0Q.D.,\u00a0 W.H. Zhao, Y.Y. Chen, Y. Chen, J.L. Shi, R. Qin,\u00a0et al.\u00a02021. RelA\/microRNA-30a\/NLRP3 signal axis is involved in rheumatoid arthritis via regulating NLRP3 inflammasome in macrophages. Cell Death and Disease\u00a012.\u00a0https:\/\/doi.org\/10.1038\/s41419-021-04349-5.","DOI":"10.1038\/s41419-021-04349-5"},{"key":"1795_CR31","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1136\/ard.2010.142091","volume":"70","author":"L Laurent","year":"2011","unstructured":"Laurent, L., C. Clavel, O. Lemaire, F. Anquetil, M. Cornillet, L. Zabraniecki, et al. 2011. Fc gamma receptor profile of monocytes and macrophages from rheumatoid arthritis patients and their response to immune complexes formed with autoantibodies to citrullinated proteins. Annals of the Rheumatic Diseases 70: 1052\u20131059. https:\/\/doi.org\/10.1136\/ard.2010.142091.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1795_CR32","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1007\/s00011-019-01244-w","volume":"68","author":"Y Liu","year":"2019","unstructured":"Liu, Y., W. Wei, Y. Wang, C. Wan, Y. Bai, X. Sun, et al. 2019. TNF-alpha\/calreticulin dual signaling induced NLRP3 inflammasome activation associated with HuR nucleocytoplasmic shuttling in rheumatoid arthritis. Inflammation Research 68: 597\u2013611. https:\/\/doi.org\/10.1007\/s00011-019-01244-w.","journal-title":"Inflammation Research"},{"key":"1795_CR33","doi-asserted-by":"publisher","unstructured":"Zucal, C., V. D'Agostino, R. Loffredo, B. Mantelli, NatthakanThongon, P. Lal,\u00a0et al.\u00a02015. Targeting the multifaceted HuR protein, benefits and caveats. Current Drug Targets\u00a016: 499\u2013515.\u00a0https:\/\/doi.org\/10.2174\/1389450116666150223163632.","DOI":"10.2174\/1389450116666150223163632"},{"key":"1795_CR34","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson, K.V., M. Deng, and J.P. Ting. 2019. The NLRP3 inflammasome: Molecular activation and regulation to therapeutics. Nature Reviews Immunology 19: 477\u2013489. https:\/\/doi.org\/10.1038\/s41577-019-0165-0.","journal-title":"Nature Reviews Immunology"},{"key":"1795_CR35","doi-asserted-by":"publisher","unstructured":"Dayer, J.M. 2003. The pivotal role of interleukin-1 in the clinical manifestations of rheumatoid arthritis. Rheumatology (Oxford)\u00a042 Suppl 2: ii3\u201310. https:\/\/doi.org\/10.1093\/rheumatology\/keg326.","DOI":"10.1093\/rheumatology\/keg326"},{"key":"1795_CR36","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.immuni.2013.05.016","volume":"38","author":"R Munoz-Planillo","year":"2013","unstructured":"Munoz-Planillo, R., P. Kuffa, G. Martinez-Colon, B.L. Smith, T.M. Rajendiran, and G. Nunez. 2013. K+ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter. Immunity 38: 1142\u20131153. https:\/\/doi.org\/10.1016\/j.immuni.2013.05.016.","journal-title":"Immunity"},{"key":"1795_CR37","doi-asserted-by":"publisher","unstructured":"Fan, Z.D., Y.Y. Zhang, Y.H. Guo, N. Huang, H.H. Ma, H. Huang,\u00a0et al.\u00a02016. Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice. Scientific Reports United Kingdom\u00a06. https:\/\/doi.org\/10.1038\/srep35804.","DOI":"10.1038\/srep35804"},{"key":"1795_CR38","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.humimm.2010.05.008","volume":"71","author":"L Portales-Cervantes","year":"2010","unstructured":"Portales-Cervantes, L., P. Nino-Moreno, L. Doniz-Padilla, L. Baranda-Candido, M. Garcia-Hernandez, M. Salgado-Bustamante, et al. 2010. Expression and function of the P2X(7) purinergic receptor in patients with systemic lupus erythematosus and rheumatoid arthritis. Human Immunology 71: 818\u2013825. https:\/\/doi.org\/10.1016\/j.humimm.2010.05.008.","journal-title":"Human Immunology"},{"key":"1795_CR39","doi-asserted-by":"publisher","unstructured":"Purohit, R., A.K. Bera. 2021. Pannexin 1 plays a pro-survival role by attenuating P2X7 receptor-mediated Ca2+ influx. Cell Calcium\u00a099.\u00a0https:\/\/doi.org\/10.1016\/j.ceca.2021.102458.","DOI":"10.1016\/j.ceca.2021.102458"},{"key":"1795_CR40","doi-asserted-by":"publisher","unstructured":"Li, Y.Y., Y. Shen, K. Jin, Z.K. Wen, W.Q. Cao, B.W. Wu,\u00a0et al.\u00a02019. The DNA repair nuclease MRE11A functions as a mitochondrial protector and prevents T cell pyroptosis and tissue inflammation. Cell Metabolism, 2019;30: 477-+.\u00a0https:\/\/doi.org\/10.1016\/j.cmet.2019.06.016.","DOI":"10.1016\/j.cmet.2019.06.016"},{"key":"1795_CR41","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1038\/nrm1154","volume":"4","author":"AM Hofer","year":"2003","unstructured":"Hofer, A.M., and E.M. Brown. 2003. Extracellular calcium sensing and signalling. Nature Reviews Molecular Cell Biology 4: 530\u2013538. https:\/\/doi.org\/10.1038\/nrm1154.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"1795_CR42","doi-asserted-by":"publisher","unstructured":"Liao, J., S. Zhang, S. Yang, Y. Lu, K. Lu, Y. Wu et al. Interleukin-6-mediated-Ca(2+) handling abnormalities contributes to atrial fibrillation in sterile pericarditis rats. Frontiers in Immunology, 2021;12: 758157.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2021.758157.","DOI":"10.3389\/fimmu.2021.758157"},{"key":"1795_CR43","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1136\/annrheumdis-2014-eular.2377","volume":"73","author":"J Paccou","year":"2014","unstructured":"Paccou, J., C. Boudot, C. Renard, S. Liabeuf, S. Kamel, P. Fardellone, et al. 2014. Total calcium-sensing receptor expression in circulating monocytes is increased in rheumatoid arthritis patients with severe coronary artery calcification. Annals of the Rheumatic Diseases 73: 846\u2013846. https:\/\/doi.org\/10.1136\/annrheumdis-2014-eular.2377.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1795_CR44","doi-asserted-by":"publisher","unstructured":"Lee, G.S., N. Subramanian, A.I. Kim, I. Aksentijevich, R. Goldbach-Mansky, D.B. Sacks,\u00a0et al.\u00a02012. The calcium-sensing receptor regulates the NLRP3 inflammasome through Ca2+ and cAMP. Nature\u00a0492: 123-+. https:\/\/doi.org\/10.1038\/nature11588.","DOI":"10.1038\/nature11588"},{"key":"1795_CR45","doi-asserted-by":"publisher","unstructured":"Rossol, M., M. Pierer, N. Raulien, D. Quandt, U. Meusch, K. Rothe,\u00a0et al.\u00a02012. Extracellular Ca2+ is a danger signal activating the NLRP3 inflammasome through G protein-coupled calcium sensing receptors. Nature Communications\u00a03. https:\/\/doi.org\/10.1038\/ncomms2339.","DOI":"10.1038\/ncomms2339"},{"key":"1795_CR46","doi-asserted-by":"publisher","unstructured":"Damgaard, D., L. Senolt, M.F. Nielsen, G.J. Pruijn, and C.H. Nielsen. 2014. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen. Arthritis Research & Therapy\u00a016. https:\/\/doi.org\/10.1186\/s13075-014-0498-9.","DOI":"10.1186\/s13075-014-0498-9"},{"key":"1795_CR47","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.cell.2015.01.004","volume":"160","author":"E Bonavita","year":"2015","unstructured":"Bonavita, E., S. Gentile, M. Rubino, V. Maina, R. Papait, P. Kunderfranco, et al. 2015. PTX3 is an extrinsic oncosuppressor regulating complement-dependent inflammation in cancer. Cell 160: 700\u2013714. https:\/\/doi.org\/10.1016\/j.cell.2015.01.004.","journal-title":"Cell"},{"key":"1795_CR48","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.immuni.2012.01.009","volume":"36","author":"K Shimada","year":"2012","unstructured":"Shimada, K., T.R. Crother, J. Karlin, J. Dagvadorj, N. Chiba, S. Chen, et al. 2012. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36: 401\u2013414. https:\/\/doi.org\/10.1016\/j.immuni.2012.01.009.","journal-title":"Immunity"},{"key":"1795_CR49","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1093\/rheumatology\/kex041","volume":"56","author":"A Contis","year":"2017","unstructured":"Contis, A., S. Mitrovic, J. Lavie, I. Douchet, E. Lazaro, M.E. Truchetet, et al. 2017. Neutrophil-derived mitochondrial DNA promotes receptor activator of nuclear factor kappaB and its ligand signalling in rheumatoid arthritis. Rheumatology (Oxford) 56: 1200\u20131205. https:\/\/doi.org\/10.1093\/rheumatology\/kex041.","journal-title":"Rheumatology (Oxford)"},{"key":"1795_CR50","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/nature09663","volume":"469","author":"R Zhou","year":"2011","unstructured":"Zhou, R., A.S. Yazdi, P. Menu, and J. Tschopp. 2011. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221\u2013225. https:\/\/doi.org\/10.1038\/nature09663.","journal-title":"Nature"},{"key":"1795_CR51","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/ni.1980","volume":"12","author":"K Nakahira","year":"2011","unstructured":"Nakahira, K., J.A. Haspel, V.A. Rathinam, S.J. Lee, T. Dolinay, H.C. Lam, et al. 2011. Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome. Nature Immunology 12: 222\u2013230. https:\/\/doi.org\/10.1038\/ni.1980.","journal-title":"Nature Immunology"},{"key":"1795_CR52","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/imr.12838","volume":"294","author":"CM Weyand","year":"2020","unstructured":"Weyand, C.M., and J.J. Goronzy. 2020. Immunometabolism in the development of rheumatoid arthritis. Immunological Reviews 294: 177\u2013187. https:\/\/doi.org\/10.1111\/imr.12838.","journal-title":"Immunological Reviews"},{"key":"1795_CR53","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1038\/ncomms2608","volume":"4","author":"Z Zhong","year":"2013","unstructured":"Zhong, Z., Y. Zhai, S. Liang, Y. Mori, R. Han, F.S. Sutterwala, et al. 2013. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nature Communications 4: 1611. https:\/\/doi.org\/10.1038\/ncomms2608.","journal-title":"Nature Communications"},{"key":"1795_CR54","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.tcb.2013.11.008","volume":"24","author":"E Mills","year":"2014","unstructured":"Mills, E., and L.A. O\u2019Neill. 2014. Succinate: A metabolic signal in inflammation. Trends in Cell Biology 24: 313\u2013320. https:\/\/doi.org\/10.1016\/j.tcb.2013.11.008.","journal-title":"Trends in Cell Biology"},{"key":"1795_CR55","doi-asserted-by":"publisher","unstructured":"Borenstein, D.G., C.A. and Gibbs, R.P. Jacobs. 1982. Gas-liquid chromatographic analysis of synovial fluid. Succinic acid and lactic acid as markers for septic arthritis. Arthritis & Rheumatology\u00a025: 947\u201353. https:\/\/doi.org\/10.1002\/art.1780250806.","DOI":"10.1002\/art.1780250806"},{"key":"1795_CR56","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1084\/jem.20160061","volume":"213","author":"A Littlewood-Evans","year":"2016","unstructured":"Littlewood-Evans, A., S. Sarret, V. Apfel, P. Loesle, J. Dawson, J. Zhang, et al. 2016. GPR91 senses extracellular succinate released from inflammatory macrophages and exacerbates rheumatoid arthritis. Journal of Experimental Medicine 213: 1655\u20131662. https:\/\/doi.org\/10.1084\/jem.20160061.","journal-title":"Journal of Experimental Medicine"},{"key":"1795_CR57","doi-asserted-by":"publisher","first-page":"3394","DOI":"10.1182\/blood-2013-08-518282","volume":"122","author":"CA Dinarello","year":"2013","unstructured":"Dinarello, C.A. 2013. The C3a receptor, caspase-1, and release of IL-1beta. Blood 122: 3394\u20133395. https:\/\/doi.org\/10.1182\/blood-2013-08-518282.","journal-title":"Blood"},{"key":"1795_CR58","doi-asserted-by":"publisher","unstructured":"Friscic, J., M. Bottcher, C. Reinwald, H. Bruns, B. Wirth, S.J. Popp,\u00a0et al. 2021. The complement system drives local inflammatory tissue priming by metabolic reprogramming of synovial fibroblasts. Immunity, 54: 1002-+.\u00a0https:\/\/doi.org\/10.1016\/j.immuni.2021.03.003.","DOI":"10.1016\/j.immuni.2021.03.003"},{"key":"1795_CR59","doi-asserted-by":"crossref","unstructured":"Wu, X.Y. 2020. Complement C1q synergizes with PTX3 in promoting NLRP3 inflammasome over-activation and pyroptosis in rheumatoid arthritis. Journal of Immunology\u00a0204.","DOI":"10.1016\/j.jaut.2019.102336"},{"key":"1795_CR60","doi-asserted-by":"publisher","unstructured":"Lu, J.H., Y.Q. Liu, Q.W. Deng, Y.P. Peng, and Y.H. Qiu. 2015. Dopamine D2 receptor is involved in alleviation of type II collagen-induced arthritis in mice. Biomed Research International\u00a02015. https:\/\/doi.org\/10.1155\/2015\/496759.","DOI":"10.1155\/2015\/496759"},{"key":"1795_CR61","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/ni.1631","volume":"9","author":"V Hornung","year":"2008","unstructured":"Hornung, V., F. Bauernfeind, A. Halle, E.O. Samstad, H. Kono, K.L. Rock, et al. 2008. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nature Immunology 9: 847\u2013856. https:\/\/doi.org\/10.1038\/ni.1631.","journal-title":"Nature Immunology"},{"key":"1795_CR62","doi-asserted-by":"publisher","unstructured":"Mathews,\u00a0R.J., J.I. Robinson, M. Battellino, C. Wong, J.C. Taylor, G. Biologics in Rheumatoid Arthritis,\u00a0et al.\u00a02014. Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment. Annals of the Rheumatic Disease\u00a073: 1202\u201310.\u00a0https:\/\/doi.org\/10.1136\/annrheumdis-2013-203276.","DOI":"10.1136\/annrheumdis-2013-203276"},{"key":"1795_CR63","doi-asserted-by":"publisher","unstructured":"Shin,\u00a0T.H., H.S. Kim, T.W. Kang, B.C. Lee, H.Y. Lee, Y.J. Kim,\u00a0et al.\u00a02016. Human umbilical cord blood-stem cells direct macrophage polarization and block inflammasome activation to alleviate rheumatoid arthritis. Cell Death Disease\u00a07. https:\/\/doi.org\/10.1038\/cddis.2016.442.","DOI":"10.1038\/cddis.2016.442"},{"key":"1795_CR64","doi-asserted-by":"publisher","first-page":"4003","DOI":"10.4049\/jimmunol.0802173","volume":"183","author":"L Kolly","year":"2009","unstructured":"Kolly, L., M. Karababa, L.A.B. Joosten, S. Narayan, R. Salvi, V. Petrilli, et al. 2009. Inflammatory role of ASC in antigen-induced arthritis is independent of caspase-1, NALP-3, and IPAF. Journal of Immunology 183: 4003\u20134012. https:\/\/doi.org\/10.4049\/jimmunol.0802173.","journal-title":"Journal of Immunology"},{"key":"1795_CR65","doi-asserted-by":"publisher","first-page":"12454","DOI":"10.1074\/jbc.M109.093252","volume":"285","author":"SK Ippagunta","year":"2010","unstructured":"Ippagunta, S.K., D.D. Brand, J.W. Luo, K.L. Boyd, C. Calabrese, R. Stienstra, et al. 2010. Inflammasome-independent role of apoptosis-associated speck-like protein containing a CARD (ASC) in T cell priming is critical for collagen-induced arthritis. Journal of Biological Chemistry 285: 12454\u201312462. https:\/\/doi.org\/10.1074\/jbc.M109.093252.","journal-title":"Journal of Biological Chemistry"},{"key":"1795_CR66","doi-asserted-by":"publisher","unstructured":"Zhang,\u00a0Y.F., Y. Zheng, H.B. Li. 2016. NLRP3 inflammasome plays an important role in the pathogenesis of collagen-induced arthritis. Mediators Inflammation\u00a02016.\u00a0https:\/\/doi.org\/10.1155\/2016\/9656270.","DOI":"10.1155\/2016\/9656270"},{"key":"1795_CR67","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00281-007-0082-3","volume":"29","author":"S Taniguchi","year":"2007","unstructured":"Taniguchi, S., and J. Sagara. 2007. Regulatory molecules involved in inflammasome formation with special reference to a key mediator protein. ASC. Semin Immunopathol 29: 231\u2013238. https:\/\/doi.org\/10.1007\/s00281-007-0082-3.","journal-title":"ASC. Semin Immunopathol"},{"key":"1795_CR68","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","volume":"27","author":"F Martinon","year":"2009","unstructured":"Martinon, F., A. Mayor, and J. Tschopp. 2009. The inflammasomes: Guardians of the body. Annual Review of Immunology 27: 229\u2013265. https:\/\/doi.org\/10.1146\/annurev.immunol.021908.132715.","journal-title":"Annual Review of Immunology"},{"key":"1795_CR69","doi-asserted-by":"publisher","unstructured":"Vande Walle, L., N. Van Opdenbosch, P. Jacques, A. Fossoul, E. Verheugen, P. Vogel,\u00a0et al.\u00a02014. Negative regulation of the NLRP3 inflammasome by A20 protects against arthritis. Nature\u00a0512: 69-+. https:\/\/doi.org\/10.1038\/nature13322.","DOI":"10.1038\/nature13322"},{"key":"1795_CR70","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1093\/rheumatology\/38.11.1058","volume":"38","author":"Z Yin","year":"1999","unstructured":"Yin, Z., S. Siegert, L. Neure, M. Grolms, L. Liu, U. Eggens, et al. 1999. The elevated ratio of interferon gamma-\/interleukin-4-positive T cells found in synovial fluid and synovial membrane of rheumatoid arthritis patients can be changed by interleukin-4 but not by interleukin-10 or transforming growth factor beta. Rheumatology 38: 1058\u20131067. https:\/\/doi.org\/10.1093\/rheumatology\/38.11.1058.","journal-title":"Rheumatology"},{"key":"1795_CR71","doi-asserted-by":"publisher","unstructured":"Dolhain,\u00a0R.J.E.M., A.N. vanderHeiden, N.T. terHaar, F.C. Breedveld, A.M.M. Miltenburg. 1996. Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis. Arthritis Rheumatoid-Us\u00a039: 1961\u20131969.\u00a0https:\/\/doi.org\/10.1002\/art.1780391204.","DOI":"10.1002\/art.1780391204"},{"key":"1795_CR72","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/1529-0131(200103)44:3<561::Aid-Anr104>3.0.Co;2-Z","volume":"44","author":"SH Park","year":"2001","unstructured":"Park, S.H., D.J. Min, M.L. Cho, W.U. Kim, J. Youn, W. Park, et al. 2001. Shift toward T helper 1 cytokines by type II collagen-reactive T cells in patients with rheumatoid arthritis. Arthritis Rheum-Us 44: 561\u2013569. https:\/\/doi.org\/10.1002\/1529-0131(200103)44:3%3c561::Aid-Anr104%3e3.0.Co;2-Z.","journal-title":"Arthritis Rheum-Us"},{"key":"1795_CR73","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1053\/berh.2001.0187","volume":"15","author":"H Schulze-Koops","year":"2001","unstructured":"Schulze-Koops, H., and J.K. Kalden. 2001. The balance of Th1\/Th2 cytokines in rheumatoid arthritis. Best Practice & Research Clinical Rheumatology 15: 677\u2013691. https:\/\/doi.org\/10.1053\/berh.2001.0187.","journal-title":"Best Practice & Research Clinical Rheumatology"},{"key":"1795_CR74","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.ejphar.2018.04.028","volume":"831","author":"SY Wu","year":"2018","unstructured":"Wu, S.Y., Y.O. Zhou, S.J. Liu, H.L. Zhang, H. Luo, X.X. Zuo, et al. 2018. Regulatory effect of nicotine on the differentiation of Th1, Th2 and Th17 lymphocyte subsets in patients with rheumatoid arthritis. European Journal of Pharmacology 831: 38\u201345. https:\/\/doi.org\/10.1016\/j.ejphar.2018.04.028.","journal-title":"European Journal of Pharmacology"},{"key":"1795_CR75","doi-asserted-by":"publisher","unstructured":"Bao, Y., J. Peng, K.L. Yang, C.H. Wang, Y.F. Guo, Z.S. Guo,\u00a0et al.\u00a02022. Therapeutic effects of Chinese medicine Di-Long (Pheretima vulgaris) on rheumatoid arthritis through inhibiting NF-kappaB activation and regulating Th1\/Th2 balance. Biomed Pharmacotherapy\u00a0147: 112643.\u00a0https:\/\/doi.org\/10.1016\/j.biopha.2022.112643.","DOI":"10.1016\/j.biopha.2022.112643"},{"key":"1795_CR76","doi-asserted-by":"publisher","first-page":"4850","DOI":"10.4049\/jimmunol.169.9.4850","volume":"169","author":"ARM Almeida","year":"2002","unstructured":"Almeida, A.R.M., N. Legrand, M. Papiernik, and A.A. Freitas. 2002. Homeostasis of peripheral CD4(+) T cells: IL-2R alpha and IL-2 shape a population of regulatory cells that controls CD4(+) T cell numbers. Journal of Immunology 169: 4850\u20134860. https:\/\/doi.org\/10.4049\/jimmunol.169.9.4850.","journal-title":"Journal of Immunology"},{"key":"1795_CR77","doi-asserted-by":"publisher","first-page":"R402","DOI":"10.1186\/ar1500","volume":"7","author":"H Kelchtermans","year":"2005","unstructured":"Kelchtermans, H., B. De Klerck, T. Mitera, M. Van Balen, D. Bullens, A. Billiau, et al. 2005. Defective CD4(+)CD25(+) regulatory T cell functioning in collagen-induced arthritis: An important factor in pathogenesis, counter-regulated by endogenous IFN-gamma. Arthritis Research & Therapy 7: R402\u2013R415. https:\/\/doi.org\/10.1186\/ar1500.","journal-title":"Arthritis Research & Therapy"},{"key":"1795_CR78","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1007\/s10875-005-4092-4","volume":"25","author":"M Kawashima","year":"2005","unstructured":"Kawashima, M., and P. Miossec. 2005. mRNA quantification of T-bet, GATA-3, IFN-gamma, and IL-4 shows a defective Th1 immune response in the peripheral blood from rheumatoid arthritis patients: Link with disease activity. Journal of Clinical Immunology 25: 209\u2013214. https:\/\/doi.org\/10.1007\/s10875-005-4092-4.","journal-title":"Journal of Clinical Immunology"},{"key":"1795_CR79","doi-asserted-by":"publisher","unstructured":"vanRoon,\u00a0J.A.G., C.M. Verhoef, J.L.A.M. vanRoy, F.H.J. GmeligMeyling, O. HuberBruning, F.P. J.G. Lafeber,\u00a0et al.\u00a01997. Decrease in peripheral type 1 over type 2 T cell cytokine production in patients with rheumatoid arthritis correlates with an increase in severity of disease. Annals of the Rheumatic Disease\u00a056: 656\u2013660.https:\/\/doi.org\/10.1136\/ard.56.11.656.","DOI":"10.1136\/ard.56.11.656"},{"key":"1795_CR80","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1084\/jem.20061341","volume":"203","author":"J Lohr","year":"2006","unstructured":"Lohr, J., B. Knoechel, J.J. Wang, A.V. Villarino, and A.K. Abbas. 2006. Role of IL-17 and regulatory T lymphocytes in a systemic autoimmune disease. Journal of Experimental Medicine 203: 2785\u20132791. https:\/\/doi.org\/10.1084\/jem.20061341.","journal-title":"Journal of Experimental Medicine"},{"key":"1795_CR81","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1196\/annals.1361.123","volume":"1051","author":"RE Voll","year":"2005","unstructured":"Voll, R.E., and J.R. Kalden. 2005. Do we need new treatment that goes beyond tumor necrosis factor blockers for rheumatoid arthritis? Annals. New York Academy of Sciences 1051: 799\u2013810. https:\/\/doi.org\/10.1196\/annals.1361.123.","journal-title":"Annals. New York Academy of Sciences"},{"key":"1795_CR82","doi-asserted-by":"publisher","first-page":"397","DOI":"10.5604\/17322693.948971","volume":"65","author":"A Kosmaczewska","year":"2011","unstructured":"Kosmaczewska, A., J. Swierkot, L. Ciszak, and P. Wiland. 2011. The role of Th1, Th17, and Treg cells in the pathogenesis of rheumatoid arthritis including anti-inflammatory action of Th1 cytokines. Post\u0119py Higieny i Medycyny Do\u015bwiadczalnej 65: 397\u2013403. https:\/\/doi.org\/10.5604\/17322693.948971.","journal-title":"Post\u0119py Higieny i Medycyny Do\u015bwiadczalnej"},{"key":"1795_CR83","doi-asserted-by":"publisher","unstructured":"Arbore, G., E.E. West, R. Spolski, A.A.B. Robertson, A. Klos, C. Rheinheimer,\u00a0et al.\u00a02016. T helper 1 immunity requires complement-driven NLRP3 inflammasome activity in CD4(+) T cells. Science\u00a0352.\u00a0https:\/\/doi.org\/10.1126\/science.aad1210.","DOI":"10.1126\/science.aad1210"},{"key":"1795_CR84","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.clim.2018.09.007","volume":"197","author":"C Zhao","year":"2018","unstructured":"Zhao, C., Y. Gu, X. Zeng, and J. Wang. 2018. NLRP3 inflammasome regulates Th17 differentiation in rheumatoid arthritis. Clinical Immunology 197: 154\u2013160. https:\/\/doi.org\/10.1016\/j.clim.2018.09.007.","journal-title":"Clinical Immunology"},{"key":"1795_CR85","doi-asserted-by":"publisher","first-page":"1560","DOI":"10.1093\/rheumatology\/ket414","volume":"53","author":"DE Furst","year":"2014","unstructured":"Furst, D.E., and P. Emery. 2014. Rheumatoid arthritis pathophysiology: Update on emerging cytokine and cytokine-associated cell targets. Rheumatology 53: 1560\u20131569. https:\/\/doi.org\/10.1093\/rheumatology\/ket414.","journal-title":"Rheumatology"},{"key":"1795_CR86","doi-asserted-by":"publisher","unstructured":"Schenk, U., M. Frascoli, M. Proietti, R. Geffers, E. Traggiai, J. Buer,\u00a0et al.\u00a02011. ATP inhibits the generation and function of regulatory T cells through the activation of purinergic P2X receptors. Science Signaling\u00a04.\u00a0https:\/\/doi.org\/10.1126\/scisignal.2001270.","DOI":"10.1126\/scisignal.2001270"},{"key":"1795_CR87","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1002\/art.10185","volume":"46","author":"YT Konttinen","year":"2002","unstructured":"Konttinen, Y.T., J. Mandelin, T.F. Li, J. Salo, J. Lassus, M. Liljestrom, et al. 2002. Acidic cysteine endoproteinase cathepsin K in the degeneration of the superficial articular hyaline cartilage in osteoarthritis. Arthritis Rheumatoid-US 46: 953\u2013960. https:\/\/doi.org\/10.1002\/art.10185.","journal-title":"Arthritis Rheumatoid-US"},{"key":"1795_CR88","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/j.autrev.2012.02.022","volume":"11","author":"R Cascao","year":"2012","unstructured":"Cascao, R., B. Vidal, H. Raquel, A. Neves-Costa, N. Figueiredo, V. Gupta, et al. 2012. Effective treatment of rat adjuvant-induced arthritis by celastrol. Autoimmunity Reviews 11: 856\u2013862. https:\/\/doi.org\/10.1016\/j.autrev.2012.02.022.","journal-title":"Autoimmunity Reviews"},{"key":"1795_CR89","doi-asserted-by":"publisher","first-page":"639","DOI":"10.3389\/fimmu.2015.00639","volume":"6","author":"S Omenetti","year":"2015","unstructured":"Omenetti, S., and T.T. Pizarro. 2015. The Treg\/Th17 axis: A dynamic balance regulated by the gut microbiome. Frontiers in Immunology 6: 639. https:\/\/doi.org\/10.3389\/fimmu.2015.00639.","journal-title":"Frontiers in Immunology"},{"key":"1795_CR90","first-page":"1128","volume":"27","author":"B Berner","year":"2000","unstructured":"Berner, B., D. Akca, T. Jung, G.A. Muller, and M.A. Reuss-Borst. 2000. Analysis of Th1 and Th2 cytokines expressing CD4+ and CD8+ T cells in rheumatoid arthritis by flow cytometry. Journal of Rheumatology 27: 1128\u20131135.","journal-title":"Journal of Rheumatology"},{"key":"1795_CR91","doi-asserted-by":"publisher","first-page":"4107","DOI":"10.1182\/blood-2003-04-1320","volume":"102","author":"L Cosmi","year":"2003","unstructured":"Cosmi, L., F. Liotta, E. Lazzeri, M. Francalanci, R. Angeli, B. Mazzinghi, et al. 2003. Human CD8(+)CD25(+) thymocytes share phenotypic and functional features with CD4(+)CD25(+) re latory thyrnocytes. Blood 102: 4107\u20134114. https:\/\/doi.org\/10.1182\/blood-2003-04-1320.","journal-title":"Blood"},{"key":"1795_CR92","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.autrev.2012.07.011","volume":"12","author":"H Carvalheiro","year":"2013","unstructured":"Carvalheiro, H., J.A.P. da Silva, and M.M. Souto-Carneiro. 2013. Potential roles for CD8(+) T cells in rheumatoid arthritis. Autoimmunity Reviews 12: 401\u2013409. https:\/\/doi.org\/10.1016\/j.autrev.2012.07.011.","journal-title":"Autoimmunity Reviews"},{"key":"1795_CR93","doi-asserted-by":"publisher","unstructured":"Tripathy, A., S. Khanna, P. Padhan, S. Smita, S. Raghav, B. Gupta. 2017. Direct recognition of LPS drive TLR4 expressing CD8(+) T cell activation in patients with rheumatoid arthritis. Scientific Reports-UK\u00a07.\u00a0https:\/\/doi.org\/10.1038\/s41598-017-01033-7.","DOI":"10.1038\/s41598-017-01033-7"},{"key":"1795_CR94","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.arcmed.2020.12.010","volume":"52","author":"A Tripathy","year":"2021","unstructured":"Tripathy, A., P. Padhan, N. Swain, S.K. Raghav, and B. Gupta. 2021. Increased extracellular ATP in plasma of rheumatoid arthritis patients activates CD8(+) T cells. Archives of Medical Research 52: 423\u2013433. https:\/\/doi.org\/10.1016\/j.arcmed.2020.12.010.","journal-title":"Archives of Medical Research"},{"key":"1795_CR95","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.immunol.20.100201.131730","volume":"20","author":"JH Russell","year":"2002","unstructured":"Russell, J.H., and T.J. Ley. 2002. Lymphocyte-mediated cytotoxicity. Annual Review of Immunology 20: 323\u2013370. https:\/\/doi.org\/10.1146\/annurev.immunol.20.100201.131730.","journal-title":"Annual Review of Immunology"},{"key":"1795_CR96","doi-asserted-by":"publisher","unstructured":"Floudas, A., N. Neto, V. Marzaioli, K. Murray, B. Moran, M. Monaghan,\u00a0et al.\u00a02020.\u00a0Pathogenic, glycolytic PD-1(+) B cells accumulate in the hypoxic RA joint. Arthritis Rheumatology\u00a072. https:\/\/doi.org\/10.1172\/jci.insight.139032.","DOI":"10.1172\/jci.insight.139032"},{"key":"1795_CR97","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.4049\/jimmunol.172.6.3422","volume":"172","author":"ME Duddy","year":"2004","unstructured":"Duddy, M.E., A. Alter, and A. Bar-Or. 2004. Distinct profiles of human B cell effector cytokines: A role in immune regulation? Journal of Immunology 172: 3422\u20133427. https:\/\/doi.org\/10.4049\/jimmunol.172.6.3422.","journal-title":"Journal of Immunology"},{"key":"1795_CR98","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/rheumatology\/keq338","volume":"50","author":"RA Moura","year":"2011","unstructured":"Moura, R.A., R. Cascao, I. Perpetuo, H. Canhao, E. Vieira-Sousa, A.F. Mourao, et al. 2011. Cytokine pattern in very early rheumatoid arthritis favours B-cell activation and survival. Rheumatology 50: 278\u2013282. https:\/\/doi.org\/10.1093\/rheumatology\/keq338.","journal-title":"Rheumatology"},{"key":"1795_CR99","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1038\/s41401-020-00582-4","volume":"42","author":"LL Zhang","year":"2021","unstructured":"Zhang, L.L., H. Xiao, F. Zhang, Y.J. Wu, J.L. Shu, Y. Li, et al. 2021. BAFF, involved in B cell activation through the NF-kappa B pathway, is related to disease activity and bone destruction in rheumatoid arthritis. Acta Pharmacologica Sinica 42: 1665\u20131675. https:\/\/doi.org\/10.1038\/s41401-020-00582-4.","journal-title":"Acta Pharmacologica Sinica"},{"key":"1795_CR100","doi-asserted-by":"publisher","unstructured":"Lim, K.H., L.C. Chen, K.T. Hsu, C.C. Chang, C.Y. Chang, C.W. Kao,\u00a0et al.\u00a02020. BAFF-driven NLRP3 inflammasome activation in B cells. Cell Death Disease\u00a011.\u00a0https:\/\/doi.org\/10.1038\/s41419-020-03035-2.","DOI":"10.1038\/s41419-020-03035-2"},{"key":"1795_CR101","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1083\/jcb.200903124","volume":"187","author":"M Lamkanfi","year":"2009","unstructured":"Lamkanfi, M., J.L. Mueller, A.C. Vitari, S. Misaghi, A. Fedorova, K. Deshayes, et al. 2009. Glyburide inhibits the cryopyrin\/Nalp3 inflammasome. Journal of Cell Biology 187: 61\u201370. https:\/\/doi.org\/10.1083\/jcb.200903124.","journal-title":"Journal of Cell Biology"},{"key":"1795_CR102","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1097\/Fjc.0000000000000070","volume":"63","author":"MJ Lipinski","year":"2014","unstructured":"Lipinski, M.J., and J.C. Frias. 2014. Molecule 16673\u201334-0: A new tool in our arsenal against inflammation. J Cardiovasc Pharm 63: 314\u2013315. https:\/\/doi.org\/10.1097\/Fjc.0000000000000070.","journal-title":"J Cardiovasc Pharm"},{"key":"1795_CR103","doi-asserted-by":"publisher","first-page":"2194","DOI":"10.1021\/acschemneuro.7b00124","volume":"8","author":"CQ Guo","year":"2017","unstructured":"Guo, C.Q., J.W. Fulp, Y.Q. Jiang, X. Li, J.E. Chojnacki, J.D. Wu, et al. 2017. Development and characterization of a hydroxyl-sulfonamide analogue, 5-chloro-N-[2-(4-hydroxysulfamoyl-phenyl)-ethyl]-2-methoxy-benzamide, as a novel NLRP3 inflammasome inhibitor for potential treatment of multiple sclerosis. ACS Chemical Neuroscience 8: 2194\u20132201. https:\/\/doi.org\/10.1021\/acschemneuro.7b00124.","journal-title":"ACS Chemical Neuroscience"},{"key":"1795_CR104","doi-asserted-by":"publisher","unstructured":"Wu, F.P., J.F. Gao, J. Kang, X.X. Wang, Q. Niu, J.X. Liu,\u00a0et al.\u00a02021. B cells in rheumatoid arthritis:pathogenic mechanisms and treatment prospects. Frontiers in Immunology\u00a012.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2021.750753.","DOI":"10.3389\/fimmu.2021.750753"},{"key":"1795_CR105","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1189\/jlb.0703328","volume":"75","author":"LV Collins","year":"2004","unstructured":"Collins, L.V., S. Hajizadeh, E. Holme, I.M. Jonsson, and A. Tarkowski. 2004. Endogenously oxidized mitochondrial DNA induces in vivo and in vitro inflammatory responses. Journal of Leukocyte Biology 75: 995\u20131000. https:\/\/doi.org\/10.1189\/jlb.0703328.","journal-title":"Journal of Leukocyte Biology"},{"key":"1795_CR106","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle, W.J., W.S. Simonet, and D.L. Lacey. 2003. Osteoclast differentiation and activation. Nature 423: 337\u2013342. https:\/\/doi.org\/10.1038\/nature01658.","journal-title":"Nature"},{"key":"1795_CR107","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1172\/Jci31935","volume":"117","author":"KA Gelderman","year":"2007","unstructured":"Gelderman, K.A., M. Hultqvist, A. Pizzolla, M. Zhao, K.S. Nandakumar, R. Mattsson, et al. 2007. Macrophages suppress T cell responses and arthritis development in mice by producing reactive oxygen species. The Journal of Clinical Investigation 117: 3020\u20133028. https:\/\/doi.org\/10.1172\/Jci31935.","journal-title":"The Journal of Clinical Investigation"},{"key":"1795_CR108","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1136\/annrheumdis-2017-212647","volume":"77","author":"M Zeisbrich","year":"2018","unstructured":"Zeisbrich, M., R.E. Yanes, H. Zhang, R. Watanabe, Y.Y. Li, L. Brosig, et al. 2018. Hypermetabolic macrophages in rheumatoid arthritis and coronary artery disease due to glycogen synthase kinase 3b inactivation. Annals of the Rheumatic Diseases 77: 1053\u20131062. https:\/\/doi.org\/10.1136\/annrheumdis-2017-212647.","journal-title":"Annals of the Rheumatic Diseases"},{"key":"1795_CR109","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s00441-009-0844-4","volume":"339","author":"MK Gordon","year":"2010","unstructured":"Gordon, M.K., and R.A. Hahn. 2010. Collagens. Cell and Tissue Research 339: 247\u2013257. https:\/\/doi.org\/10.1007\/s00441-009-0844-4.","journal-title":"Cell and Tissue Research"},{"key":"1795_CR110","first-page":"12","volume":"34","author":"Z Zhong","year":"2016","unstructured":"Zhong, Z., E. Sanchez-Lopez, and M. Karin. 2016. Autophagy, NLRP3 inflammasome and auto-inflammatory\/immune diseases. Clinical and Experimental Rheumatology 34: 12\u201316.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"1795_CR111","doi-asserted-by":"publisher","unstructured":"Yang, W., Z. Zhu, L. Li, A. McVicar, N. Gao, L. Wang,\u00a0et al.\u00a02020. Silencing of Ac45 simultaneously inhibits osteoclast-mediated bone resorption and attenuates dendritic cell-mediated inflammation through impairing acidification and cathepsin K secretion. Infect Immunology\u00a089.\u00a0https:\/\/doi.org\/10.1128\/IAI.00436-20.","DOI":"10.1128\/IAI.00436-20"},{"key":"1795_CR112","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/cei.13167","volume":"194","author":"C Guo","year":"2018","unstructured":"Guo, C., R. Fu, S. Wang, Y. Huang, X. Li, M. Zhou, et al. 2018. NLRP3 inflammasome activation contributes to the pathogenesis of rheumatoid arthritis. Clinical and Experimental Immunology 194: 231\u2013243. https:\/\/doi.org\/10.1111\/cei.13167.","journal-title":"Clinical and Experimental Immunology"},{"key":"1795_CR113","doi-asserted-by":"publisher","unstructured":"Ishida, M., N. Kawao, Y. Mizukami, Y. Takafuji, H. Kaji. 2021. Serpinb1a suppresses osteoclast formation.\u00a0Biochemistry and Biophysics Reports\u00a026: 101004. https:\/\/doi.org\/10.1016\/j.bbrep.2021.101004.","DOI":"10.1016\/j.bbrep.2021.101004"},{"key":"1795_CR114","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1021\/acs.bioconjchem.1c00036","volume":"32","author":"ET Richard","year":"2021","unstructured":"Richard, E.T., K. Morinaga, Y. Zheng, O. Sundberg, A. Hokugo, K. Hui, et al. 2021. Design and synthesis of cathepsin-K-activated osteoadsorptive fluorogenic sentinel (OFS) probes for detecting early osteoclastic bone resorption in a multiple myeloma mouse model. Bioconjugate Chemistry 32: 916\u2013927. https:\/\/doi.org\/10.1021\/acs.bioconjchem.1c00036.","journal-title":"Bioconjugate Chemistry"},{"key":"1795_CR115","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok, B., and G.S. Firestein. 2010. Fibroblast-like synoviocytes: Key effector cells in rheumatoid arthritis. Immunological Reviews 233: 233\u2013255. https:\/\/doi.org\/10.1111\/j.0105-2896.2009.00859.x.","journal-title":"Immunological Reviews"},{"key":"1795_CR116","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13287-020-01786-5","volume":"11","author":"P Neybecker","year":"2020","unstructured":"Neybecker, P., C. Henrionnet, E. Pape, L. Grossin, D. Mainard, L. Galois, et al. 2020. Respective stemness and chondrogenic potential of mesenchymal stem cells isolated from human bone marrow, synovial membrane, and synovial fluid. Stem Cell Research & Therapy 11: 316. https:\/\/doi.org\/10.1186\/s13287-020-01786-5.","journal-title":"Stem Cell Research & Therapy"},{"key":"1795_CR117","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1002\/art.1780341116","volume":"34","author":"A Trabandt","year":"1991","unstructured":"Trabandt, A., R.E. Gay, H.G. Fassbender, and S. Gay. 1991. Cathepsin-B in synovial-cells at the site of joint destruction in rheumatoid-arthritis. Arthritis Rheum-Us 34: 1444\u20131451.","journal-title":"Arthritis Rheum-Us"},{"key":"1795_CR118","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1093\/rheumatology\/38.1.34","volume":"38","author":"G Cunnane","year":"1999","unstructured":"Cunnane, G., O. FitzGerald, K.M. Hummel, R.E. Gay, S. Gay, and B. Bresnihan. 1999. Collagenase, cathepsin B and cathepsin L gene expression in the synovial membrane of patients with early inflammatory arthritis. Rheumatology 38: 34\u201342. https:\/\/doi.org\/10.1093\/rheumatology\/38.1.34.","journal-title":"Rheumatology"},{"key":"1795_CR119","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/nrd.2018.97","volume":"17","author":"MSJ Mangan","year":"2018","unstructured":"Mangan, M.S.J., E.J. Olhava, W.R. Roush, H.M. Seidel, G.D. Glick, and E. Latz. 2018. Targeting the NLRP3 inflammasome in inflammatory diseases. Nature Reviews. Drug Discovery 17: 588\u2013606. https:\/\/doi.org\/10.1038\/nrd.2018.97.","journal-title":"Nature Reviews. Drug Discovery"},{"key":"1795_CR120","doi-asserted-by":"publisher","unstructured":"Tenshin, H., J. Teramachi, M. Ashtar, M. Hiasa, Y. Inoue, A. Oda,\u00a0et al.\u00a02022. TGF-beta-activated kinase-1 inhibitor LL-Z1640\u20132 reduces joint inflammation and bone destruction in mouse models of rheumatoid arthritis by inhibiting NLRP3 inflammasome, TACE, TNF-alpha and RANKL expression. Clinical and Translational Immunology\u00a011: e1371.\u00a0https:\/\/doi.org\/10.1002\/cti2.1371.","DOI":"10.1002\/cti2.1371"},{"key":"1795_CR121","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/bs.pmbts.2017.03.002","volume":"148","author":"Y Itoh","year":"2017","unstructured":"Itoh, Y. 2017. Metalloproteinases in rheumatoid arthritis: Potential therapeutic targets to improve current therapies. Prog Mol Biol Transl 148: 327\u2013338. https:\/\/doi.org\/10.1016\/bs.pmbts.2017.03.002.","journal-title":"Prog Mol Biol Transl"},{"key":"1795_CR122","doi-asserted-by":"publisher","unstructured":"Coll,\u00a0R.C.,\u00a0 J.R. Hill, C.J. Day, A. Zamoshnikova, D. Boucher, N.L. Massey,\u00a0et al.\u00a02019. MCC950 directly targets the NLRP3 ATP- hydrolysis motif for inflammasome inhibition. Nature Chemical Biology\u00a015: 556-+.\u00a0https:\/\/doi.org\/10.1038\/s41589-019-0277-7.","DOI":"10.1038\/s41589-019-0277-7"},{"key":"1795_CR123","doi-asserted-by":"publisher","unstructured":"Coll, R.C., A.A.B. Robertson, J.J. Chae, S.C. Higgins, R. Munoz-Planillo, M.C. Inserra,\u00a0et al.\u00a02015. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nature Medicine\u00a021: 248-+.\u00a0https:\/\/doi.org\/10.1038\/nm.3806.","DOI":"10.1038\/nm.3806"},{"key":"1795_CR124","doi-asserted-by":"publisher","unstructured":"Rao, Z.B., X. Chen, J.X. Wu, M.J. Xiao, J. Zhang, B.H. Wang,\u00a0et al.\u00a02019. Vitamin D receptor inhibits NLRP3 activation by impeding its BRCC3-mediated deubiquitination. Frontiers in Immunology\u00a010.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2019.02783.","DOI":"10.3389\/fimmu.2019.02783"},{"key":"1795_CR125","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang, H., H.B. He, Y. Chen, W. Huang, J.B. Cheng, J. Ye, et al. 2017. Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. Journal of Experimental Medicine 214: 3219\u20133238. https:\/\/doi.org\/10.1084\/jem.20171419.","journal-title":"Journal of Experimental Medicine"},{"key":"1795_CR126","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.bbrc.2021.03.055","volume":"553","author":"Y Zhang","year":"2021","unstructured":"Zhang, Y., Z. Lin, D. Chen, and Y. He. 2021. CY-09 attenuates the progression of osteoarthritis via inhibiting NLRP3 inflammasome-mediated pyroptosis. Biochemical and Biophysical Research Communications 553: 119\u2013125. https:\/\/doi.org\/10.1016\/j.bbrc.2021.03.055.","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"1795_CR127","doi-asserted-by":"publisher","first-page":"S160","DOI":"10.1007\/s001250051438","volume":"40","author":"P Smits","year":"1997","unstructured":"Smits, P. 1997. Cardiovascular effects of sulphonylurea derivatives. Diabetologia 40: S160\u2013S161. https:\/\/doi.org\/10.1007\/s001250051438.","journal-title":"Diabetologia"},{"key":"1795_CR128","doi-asserted-by":"publisher","unstructured":"Marchetti, C., B. Swartzwelter, M.I. Koenders, T. Azam, I.W. Tengesdal, N. Powers,\u00a0et al.\u00a02018. NLRP3 inflammasome inhibitor OLT1177 suppresses joint inflammation in murine models of acute arthritis. Arthritis Research & Therapy\u00a020. https:\/\/doi.org\/10.1186\/s13075-018-1664-2.","DOI":"10.1186\/s13075-018-1664-2"},{"key":"1795_CR129","doi-asserted-by":"publisher","first-page":"2912","DOI":"10.1007\/s10620-021-07184-y","volume":"67","author":"T Oizumi","year":"2022","unstructured":"Oizumi, T., T. Mayanagi, Y. Toya, T. Sugai, T. Matsumoto, and K. Sobue. 2022. NLRP3 inflammasome inhibitor OLT1177 suppresses onset of inflammation in mice with dextran sulfate sodium-induced colitis. Digest Diseases and Sciences 67: 2912\u20132921. https:\/\/doi.org\/10.1007\/s10620-021-07184-y.","journal-title":"Digest Diseases and Sciences"},{"key":"1795_CR130","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1074\/jbc.M113.515080","volume":"289","author":"Y He","year":"2014","unstructured":"He, Y., S. Varadarajan, R. Munoz-Planillo, A. Burberry, Y. Nakamura, and G. Nunez. 2014. 3,4-Methylenedioxy-beta-nitrostyrene inhibits NLRP3 inflammasome activation by blocking assembly of the inflammasome. Journal of Biological Chemistry 289: 1142\u20131150. https:\/\/doi.org\/10.1074\/jbc.M113.515080.","journal-title":"Journal of Biological Chemistry"},{"key":"1795_CR131","doi-asserted-by":"publisher","unstructured":"Zheng,\u00a0J.J., Z.X. Jiang, Y. Song, S. Huang, Y.Z. Du, X.B. Yang,\u00a0et al.\u00a02022. 3,4-Methylenedioxy-beta-nitrostyrene alleviates dextran sulfate sodium-induced mouse colitis by inhibiting the NLRP3 inflammasome. Frontiers in Pharmacology\u00a013.\u00a0https:\/\/doi.org\/10.3389\/fphar.2022.866228.","DOI":"10.3389\/fphar.2022.866228"},{"key":"1795_CR132","doi-asserted-by":"publisher","unstructured":"Hu,\u00a0J.J., X. Liu, S.Y. Xia, Z.B. Zhang, Y. Zhang, J.X. Zhao,\u00a0et al.\u00a02020. FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nature Immunology\u00a021: 736-+.https:\/\/doi.org\/10.1038\/s41590-020-0669-6.","DOI":"10.1038\/s41590-020-0669-6"},{"key":"1795_CR133","doi-asserted-by":"publisher","unstructured":"Sollberger, G., A. Choidas, G.L. Burn, P. Habenberger, R. Di Lucrezia, S. Kordes,\u00a0et al. 2018. Gasdermin D plays a vital role in the generation of neutrophil extracellular traps. Science Immunology\u00a03. https:\/\/doi.org\/10.1126\/sciimmunol.aar6689.","DOI":"10.1126\/sciimmunol.aar6689"},{"key":"1795_CR134","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005121.pub3:CD005121;10.1002\/14651858.CD005121.pub3","author":"M Mertens","year":"2009","unstructured":"Mertens, M., and J.A. Singh. 2009. Anakinra for rheumatoid arthritis. Cochrane Database Systematic Review. https:\/\/doi.org\/10.1002\/14651858.CD005121.pub3:CD005121;10.1002\/14651858.CD005121.pub3.","journal-title":"Cochrane Database Systematic Review"},{"key":"1795_CR135","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.clinthera.2011.05.044","volume":"33","author":"JR Curtis","year":"2011","unstructured":"Curtis, J.R., and J.A. Singh. 2011. Use of biologics in rheumatoid arthritis: Current and emerging paradigms of care. Clinical Therapeutics 33: 679\u2013707. https:\/\/doi.org\/10.1016\/j.clinthera.2011.05.044.","journal-title":"Clinical Therapeutics"},{"key":"1795_CR136","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1159\/000493390","volume":"27","author":"J Bullock","year":"2018","unstructured":"Bullock, J., S.A.A. Rizvi, A.M. Saleh, S.S. Ahmed, D.P. Do, R.A. Ansari, et al. 2018. Rheumatoid arthritis: A brief overview of the treatment. Medical Principles and Practice 27: 501\u2013507. https:\/\/doi.org\/10.1159\/000493390.","journal-title":"Medical Principles and Practice"},{"key":"1795_CR137","doi-asserted-by":"publisher","unstructured":"Alten, R., H. Gram, L.A. Joosten, W.B. van den Berg, J. Sieper, S. Wassenberg,\u00a0et al. 2008. The human anti-IL-1 beta monoclonal antibody ACZ885 is effective in joint inflammation models in mice and in a proof-of-concept study in patients with rheumatoid arthritis. Arthritis Research & Therapy\u00a010.\u00a0https:\/\/doi.org\/10.1186\/ar2438.","DOI":"10.1186\/ar2438"},{"key":"1795_CR138","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/1471-2474-12-153","volume":"12","author":"R Alten","year":"2011","unstructured":"Alten, R., J. Gomez-Reino, P. Durez, A. Beaulieu, A. Sebba, G. Krammer, et al. 2011. Efficacy and safety of the human anti-IL-1beta monoclonal antibody canakinumab in rheumatoid arthritis: Results of a 12-week, phase II, dose-finding study. BMC Musculoskeletal Disorders 12: 153. https:\/\/doi.org\/10.1186\/1471-2474-12-153.","journal-title":"BMC Musculoskeletal Disorders"},{"key":"1795_CR139","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s00393-009-0530-7","volume":"69","author":"I Kotter","year":"2010","unstructured":"Kotter, I., and G. Horneff. 2010. IL-1 antagonists. Zeitschrift fur Rheumatologie 69: 581\u2013593. https:\/\/doi.org\/10.1007\/s00393-009-0530-7.","journal-title":"Zeitschrift fur Rheumatologie"},{"key":"1795_CR140","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1111\/j.1749-6632.2009.05074.x","volume":"1182","author":"N Stahl","year":"2009","unstructured":"Stahl, N., A. Radin, and S. Mellis. 2009. Rilonacept\u2013CAPS and beyond. Annals of the New York Academy of Sciences 1182: 124\u2013134. https:\/\/doi.org\/10.1111\/j.1749-6632.2009.05074.x.","journal-title":"Annals of the New York Academy of Sciences"},{"key":"1795_CR141","doi-asserted-by":"publisher","unstructured":"He, H.B., H. Jiang, Y. Chen, J. Ye, A. L. Wang, C. Wang,\u00a0et al.\u00a02018. Oridonin is a covalent NLRP3 inhibitor with strong anti-inflammasome activity. Nature Communications\u00a09.\u00a0https:\/\/doi.org\/10.1038\/s41467-018-04947-6.","DOI":"10.1038\/s41467-018-04947-6"},{"key":"1795_CR142","doi-asserted-by":"publisher","unstructured":"Jiang, W., M.Q. Li, F. He, S.B. Zhou, L.L. Zhu. 2017. Targeting the NLRP3 inflammasome to attenuate spinal cord injury in mice. Journal of Neuroinflammation\u00a014.\u00a0https:\/\/doi.org\/10.1186\/s12974-017-0980-9.","DOI":"10.1186\/s12974-017-0980-9"},{"key":"1795_CR143","doi-asserted-by":"publisher","unstructured":"Sanchez-Fernandez, A., D.B. Skouras, C.A. Dinarello, R. Lopez-Vales. 2019. OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis. Frontiers in Immunology.\u00a0 10.\u00a0https:\/\/doi.org\/10.3389\/fimmu.2019.02578.","DOI":"10.3389\/fimmu.2019.02578"},{"key":"1795_CR144","doi-asserted-by":"publisher","unstructured":"Aslam, M.M., P. John, A. Bhatti, S. Jahangir, M.I. Kamboh. 2019. Vitamin D as a principal factor in mediating rheumatoid arthritis-derived immune response. Biomed Research International\u00a02019.\u00a0https:\/\/doi.org\/10.1155\/2019\/3494937.","DOI":"10.1155\/2019\/3494937"},{"key":"1795_CR145","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nrrheum.2015.140","volume":"12","author":"LE Jeffery","year":"2016","unstructured":"Jeffery, L.E., K. Raza, and M. Hewison. 2016. Vitamin D in rheumatoid arthritis - towards clinical application. Nature Reviews Rheumatology 12: 201\u2013210. https:\/\/doi.org\/10.1038\/nrrheum.2015.140.","journal-title":"Nature Reviews Rheumatology"},{"key":"1795_CR146","doi-asserted-by":"publisher","first-page":"E1530","DOI":"10.1073\/pnas.1716095115","volume":"115","author":"C Marchetti","year":"2018","unstructured":"Marchetti, C., B. Swartzwelter, F. Gamboni, C.P. Neff, K. Richter, T. Azam, et al. 2018. OLT1177, a ss-sulfonyl nitrile compound, safe in humans, inhibits the NLRP3 inflammasome and reverses the metabolic cost of inflammation. Proceedings of the National Academy of Sciences USA 115: E1530\u2013E1539. https:\/\/doi.org\/10.1073\/pnas.1716095115.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"1795_CR147","doi-asserted-by":"publisher","first-page":"E270","DOI":"10.1016\/S2665-9913(20)30065-5","volume":"2","author":"V Kluck","year":"2020","unstructured":"Kluck, V., T.L.T.A. Jansen, M. Janssen, A. Comarniceanu, M. Efde, I.W. Tengesdal, et al. 2020. Dapansutrile, an oral selective NLRP3 inflammasome inhibitor, for treatment of gout flares: An open-label, dose-adaptive, proof-of-concept, phase 2a trial. Lancet Rheumatol 2: E270\u2013E280. https:\/\/doi.org\/10.1016\/S2665-9913(20)30065-5.","journal-title":"Lancet Rheumatol"},{"key":"1795_CR148","doi-asserted-by":"publisher","first-page":"32145","DOI":"10.1073\/pnas.2009680117","volume":"117","author":"N Lonnemann","year":"2020","unstructured":"Lonnemann, N., S. Hosseini, C. Marchetti, D.B. Skouras, D. Stefanoni, A. D\u2019Alessandro, et al. 2020. The NLRP3 inflammasome inhibitor OLT1177 rescues cognitive impairment in a mouse model of Alzheimer\u2019s disease. Proceedings of the National Academy of Sciences USA 117: 32145\u201332154. https:\/\/doi.org\/10.1073\/pnas.2009680117.","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"1795_CR149","doi-asserted-by":"publisher","unstructured":"Lunding,\u00a0L.P., D.B. Skouras, C. Vock, C.A. Dinarello, and M. Wegmann. 2022. The NLRP3 inflammasome inhibitor, OLT1177 (R), ameliorates experimental allergic asthma in mice. Allergy\u00a077: 1035-+.\u00a0https:\/\/doi.org\/10.1111\/all.15164.","DOI":"10.1111\/all.15164"},{"key":"1795_CR150","doi-asserted-by":"publisher","unstructured":"Yang, Y., H.N. Wang, M. Kouadir, H.H. Song, and F.S. Shi. 2019. Recent advances in the mechanisms of NLRP3 inflammasome activation and its inhibitors. Cell Death and Disease\u00a010.\u00a0https:\/\/doi.org\/10.1038\/s41419-019-1413-8.","DOI":"10.1038\/s41419-019-1413-8"},{"key":"1795_CR151","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1124\/mol.106.023986","volume":"70","author":"WY Wang","year":"2006","unstructured":"Wang, W.Y., Y.C. Wu, and C.C. Wu. 2006. Prevention of platelet glycoprotein IIb\/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor. Molecular Pharmacology 70: 1380\u20131389. https:\/\/doi.org\/10.1124\/mol.106.023986.","journal-title":"Molecular Pharmacology"},{"key":"1795_CR152","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.intimp.2017.11.026","volume":"54","author":"D Patel","year":"2018","unstructured":"Patel, D., S. Gaikwad, N. Challagundla, M. Nivsarkar, and R. Agrawal-Rajput. 2018. Spleen tyrosine kinase inhibition ameliorates airway inflammation through modulation of NLRP3 inflammosome and Th17\/Treg axis. International Immunopharmacology 54: 375\u2013384. https:\/\/doi.org\/10.1016\/j.intimp.2017.11.026.","journal-title":"International Immunopharmacology"},{"key":"1795_CR153","first-page":"111","volume":"34","author":"Y Zhang","year":"2016","unstructured":"Zhang, Y., and Y. Zheng. 2016. Effects and mechanisms of potent caspase-1 inhibitor VX765 treatment on collagen-induced arthritis in mice. Clinical and Experimental Rheumatology 34: 111\u2013118.","journal-title":"Clinical and Experimental Rheumatology"},{"key":"1795_CR154","doi-asserted-by":"publisher","unstructured":"Zhang, L., R.L. Xing, Z.Q. Huang, N.S. Zhang, L. Zhang, X.C. Li,\u00a0et al.\u00a02019. Inhibition of synovial macrophage pyroptosis alleviates synovitis and fibrosis in knee osteoarthritis. Mediators of Inflammation\u00a02019.\u00a0https:\/\/doi.org\/10.1155\/2019\/2165918.","DOI":"10.1155\/2019\/2165918"},{"key":"1795_CR155","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/0002-9343(90)90534-K","volume":"88","author":"C Wright","year":"1990","unstructured":"Wright, C., and R.D. Moore. 1990. Disulfiram treatment of alcoholism. American Journal of Medicine 88: 647\u2013655. https:\/\/doi.org\/10.1016\/0002-9343(90)90534-K.","journal-title":"American Journal of Medicine"},{"key":"1795_CR156","doi-asserted-by":"publisher","unstructured":"Liu, Z.Y., X.Q. Yao, W.S. Jiang, W. Li, S.Y. Zhu, C.R. Liao,\u00a0et al. 2020. Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-kappa B signaling pathway and pyroptosis after secondary spinal cord injury. Journal of Neuroinflammation\u00a017.\u00a0https:\/\/doi.org\/10.1186\/s12974-020-01751-2.","DOI":"10.1186\/s12974-020-01751-2"},{"key":"1795_CR157","doi-asserted-by":"publisher","DOI":"10.1089\/neu.2021.0318;10.1089\/neu.2021.0318","author":"E Yu","year":"2022","unstructured":"Yu, E., E. Zhang, X. Lv, L. Yan, Z. Lin, F. Siaw-Debrah, et al. 2022. LDC7559 exerts neuroprotective effects by inhibiting GSDMD-dependent pyroptosis of microglia in mice with traumatic brain injury. Journal of Neurotrauma. https:\/\/doi.org\/10.1089\/neu.2021.0318;10.1089\/neu.2021.0318.","journal-title":"Journal of Neurotrauma"},{"key":"1795_CR158","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1126\/science.272.5262.735","volume":"272","author":"A Surprenant","year":"1996","unstructured":"Surprenant, A., F. Rassendren, E. Kawashima, R.A. North, and G. Buell. 1996. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272: 735\u2013738. https:\/\/doi.org\/10.1126\/science.272.5262.735.","journal-title":"Science"},{"key":"1795_CR159","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1007\/s12016-019-08742-z","volume":"58","author":"MI Arleevskaya","year":"2020","unstructured":"Arleevskaya, M.I., R.V. Larionova, W.H. Brooks, E. Bettacchioli, and Y. Renaudineau. 2020. Toll-like receptors, infections, and rheumatoid arthritis. Clinical Reviews in Allergy & Immunology 58: 172\u2013181. https:\/\/doi.org\/10.1007\/s12016-019-08742-z.","journal-title":"Clinical Reviews in Allergy & Immunology"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-023-01795-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-023-01795-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,17]],"date-time":"2023-05-17T03:41:40Z","timestamp":1684294900000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-023-01795-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,10]]},"references-count":159,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["1795"],"URL":"https:\/\/doi.org\/10.1007\/s10753-023-01795-5","relation":{},"ISSN":["0360-3997","1573-2576"],"issn-type":[{"value":"0360-3997","type":"print"},{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,10]]},"assertion":[{"value":"30 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"DECLARATIONS"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}